Drug Profile
Research programme: VEGF inhibitors - Amgen
Alternative Names: AMG-273Latest Information Update: 06 Apr 2011
Price :
$50
*
At a glance
- Originator Amgen
- Class Antineoplastics
- Mechanism of Action Angiogenesis inhibitors; Platelet-derived growth factor receptor antagonists; Protein tyrosine kinase inhibitors; Vascular endothelial growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer